|
시장보고서
상품코드
2075419
Pharma 4.0 시장 : 컴포넌트별, 기술별, 용도별, 최종사용자별, 지역별Global Pharma 4.0 Market, By Component, By Technology, By Application, By End User, By Geography |
||||||
세계의 Pharma 4.0 시장은 2026년에 199억 5,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 662억 5,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 18.7%로 성장할 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 199억 5,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 18.70% | 예측 금액(2033년) | 662억 5,000만 달러 |
Pharma 4.0이란 인더스트리 4.0의 원칙에 따라 제약 업계가 변화하는 것을 의미합니다. 인더스트리 4.0은 사물인터넷(IoT), 인공지능(AI), 빅데이터 분석, 클라우드 컴퓨팅, 사이버-물리 시스템 등의 첨단 기술을 제조 공정에 통합하는 것이 특징입니다. 제약 업계에서 이는 의약품 개발, 제조, 공급망 관리 및 전반적인 업무 효율성 향상으로 이어집니다. Pharma 4.0이란 제약 업계의 4차 산업혁명을 의미하며, 사물인터넷(IoT), 빅데이터 분석, 인공지능(AI), 기계학습과 같은 첨단 기술의 통합을 특징으로 합니다. 이러한 기술들은 연구개발, 임상시험, 생산에 이르기까지 제약 밸류체인의 다양한 측면에 혁신을 가져오고 있습니다. 또한 제약 기업이 혁신적인 표적 치료법이나 정밀 의학을 개발할 수 있도록 지원함으로써, 맞춤형 헬스케어의 실현도 촉진하고 있습니다. 주요 기업이 비용 절감, 생산성 향상, 경쟁 우위 확보를 목적으로 이러한 신기술을 점점 더 많이 도입함에 따라 전 세계 Pharma 4.0 시장은 향후 수년간 큰 성장을 보일 것으로 전망됩니다.
시장 역학 :
전 세계 Pharma 4.0 시장은 신약 개발 및 개발 프로세스 개선에 대한 요구 증가, 맞춤형 의료에 대한 수요 증가, 제조 업무의 디지털화에 대한 관심 고조, 그리고 제약 기업의 공급망 가시성 및 효율성 향상을 목표로 한 노력 등 여러 요인에 의해 주도되고 있습니다. 그러나 신기술 도입에 필요한 막대한 투자 비용과 보안 침해 및 사이버 공격의 위험이 시장 성장에 걸림돌이 되고 있습니다. Pharma 4.0은 데이터베이스의 연구개발, 임상시험 및 공급망 혼란에 대한 예측 분석, 새로운 디지털 치료법 개발, 그리고 맞춤형 의약품 제조에 3D 프린팅 기술을 도입함으로써 큰 기회를 제공합니다. 주요 기업은 이러한 기회를 최대한 활용하기 위해 신제품 출시와 파트너십 구축에 주력하고 있습니다.
이 보고서의 주요 특징 :
- 이 보고서에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 이 보고서에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 보고서에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)을 바탕으로 전 세계 Pharma 4.0 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- '세계의 Pharma 4.0 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 Pharma 4.0 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 Pharma 4.0 시장 : 컴포넌트별(2021-2033년)
제5장 세계의 Pharma 4.0 시장 : 기술별(2021-2033년)
제6장 세계의 Pharma 4.0 시장 : 용도별(2021-2033년)
제7장 세계의 Pharma 4.0 시장 : 최종사용자별(2021-2033년)
제8장 세계의 Pharma 4.0 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSA 26.07.08Global Pharma 4.0 Market is estimated to be valued at USD 19.95 Bn in 2026 and is expected to reach USD 66.25 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 19.95 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 18.70% | 2033 Value Projection: | USD 66.25 Bn |
The term Pharma 4.0 refers to the transformation in the pharmaceutical industry that is aligned with the principles of Industry 4.0. Industry 4.0 is characterized by the integration of advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), big data analytics, cloud computing, and cyber-physical systems into manufacturing processes. In the context of the pharmaceutical industry, this translates to improvements in drug development, manufacturing, supply chain management, and overall operational efficiency. Pharma 4.0 refers to the fourth industrial revolution in the pharmaceutical industry, characterized by the integration of advanced technologies like the Internet of Things (IoT), big data analytics, artificial intelligence (AI), and machine learning. These technologies are revolutionizing various aspects of the pharmaceutical value chain from research and development, clinical trials, production. They are also enabling personalized healthcare by helping pharma companies develop innovative targeted therapies and precision medicine. The global pharma 4.0 market is projected to grow significantly in the coming years as major players are increasingly adopting these emerging technologies to minimize costs, enhance productivity, and gain a competitive edge.
Market Dynamics:
The global pharma 4.0 market is driven by several factors, such as the growing need to improve drug discovery and development processes, rising demand for personalized medicines, an increasing focus on digitalizing manufacturing operations, and the aims of pharmaceutical companies to enhance supply chain visibility and efficiency. However, the high investment costs required for the implementation of emerging technologies, the risks of security breaches, and cyberattacks pose challenges to market growth. Pharma 4.0 offers huge opportunities by enabling data-driven research and development, predictive analytics for clinical trials and supply chain disruptions, the development of new digital therapies, and the adoption of 3D printing for customized drug manufacturing. Key players are focusing on new product launches and partnerships to capitalize on these opportunities.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pharma 4.0 market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study Oracle,GE Healthcare, Optum, Inc., Honeywell International Inc., IBM Corporation, Cisco Systems, Inc., Siemens Healthcare GmbH, POLARISqb, Google Cloud, Optibrium, Syntekabio, Fujitsu Limited, SAS Health, Microsoft and Lotte Healthcare
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global pharma 4.0 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharma 4.0 market
Detailed Segmentation:
- Global Pharma 4.0 Market, By Component (Revenue, USD Bn, 2021 - 2033)
- Hardware
- Software
- Services
- Global Pharma 4.0 Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Cloud Computing
- Artificial Intelligence
- Big Data Analytics
- Internet of Things
- Global Pharma 4.0 Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Research and Development
- Manufacturing
- Supply Chain Management
- Others
- Global Pharma 4.0 Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Contract Research Organizations
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Pharma 4.0 Market:
- Oracle
- GE Healthcare
- Optum, Inc.
- Honeywell International Inc.
- IBM Corporation
- Cisco Systems, Inc.
- Siemens Healthcare GmbH
- POLARISqb
- Google Cloud
- Optibrium
- Syntekabio
- Fujitsu Limited
- SAS Health
- Microsoft
- Lotte Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Component
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing Product Launch
- Data Security and Privacy Concerns
- Advancements in Artificial Intelligence and Analytics
- Key Highlights
- Regulatory Scenario
- Market Trends
- PEST Analysis
- PORTER's Analysis
- Product Launches
- Technological Advancements
- Mergers, Acquisitions, and Collaborations
4. Global Pharma 4.0 Market, By Component, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Pharma 4.0 Market, By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cloud Computing,
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Artificial Intelligence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Big Data Analytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Internet of Things
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Pharma 4.0 Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Supply Chain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Pharma 4.0 Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Pharma 4.0 Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profile
- Oracle
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Optum, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Honeywell International Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IBM Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cisco Systems, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Siemens Healthcare GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- POLARISqb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Google Cloud
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Optibrium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Syntekabio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fujitsu Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SAS Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Microsoft
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lotte Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Oracle
- Analyst Views
10. Section
- References
- Research Methodology
- About us
